Predictors of Outcome in Patients With Suspected Myocarditis

By I. Kindermann, M. Kindermann, R. Kandolf, K. Klingel, B. Bültmann, T. Müller, A. Lindinger, M. Böhm. Circulation, 2008

630 citations recorded by the source corpus.

Subfields: Animal Science and Zoology, Cardiology and Cardiovascular Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/ea66152e540877b4d227f537dfd65b8a93c5ecf2

Citations in the corpus

• Myocarditis in Patients Treated With Immune Checkpoint Inhibitors (2018, neutral): “Serious cardiovascular sequelae occurred in 46% of patients who developed myocarditis after immune therapy, and importantly, in comparison to nonimmune therapy–related myocarditis (21), a depressed LVEF was not a prerequisite for serious adverse cardiovascular events.”
• 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “or IV with positive immunohistology and not receiving beta-blocker therapy died or underwent heart transplantation.(597) In patients with documented symptomatic sustained VT of un-”